An interventional study of Platform and Platform sham in Kidney Transplantation and Exercise, sponsored by Universidade Federal de Pernambuco. Status unknown at 1 site in Brazil. Open to participants aged 18 Years to 59 Years. Per ClinicalTrials.gov, last updated 2017-04-19.
Sponsored by Universidade Federal de Pernambuco · Not applicable, Interventional, and Treatment
Evaluate the effectiveness of a Whole body vibration training program on quadriceps muscle strength, functional capacity and respiratory muscle strength in adult renal transplant recipients
The study will be a randomized controlled clinical trial involving adult renal transplant recipients, who will be recruited through eligibility criteria at Nephrology outpatient clinics of the Kidney Transplantation Centers of the Hospital das Clínicas of the Federal University of Pernambuco (HC-UFPE). Individuals will be randomized and assigned to one of the following groups: Platform Group, which will perform 12-week whole body vibration training or Platform SHAM Group that will receive treatment without the therapeutic effect of the platform. Afterwards, the patients will be submitted to an evaluation, a form with sociodemographic data, the clinical history of the disease and the laboratory tests will be completed, after which the pulmonary function, respiratory muscle strength, quadriceps muscle strength and thickness, postural balance , Functional capacity, quality of life, risk of falls and level of physical activity.
Universidade Federal de Pernambuco is the lead sponsor of 161 studies on the registry; 21 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Group submitted to the whole body vibration training program
Other: Platform
Group that will receive the whole body vibration simulation treatment without the therapeutic effect of the platform, but with vibrating platform connected with the display on and a sound device coupled with vibration-generated noise recording, but without therapeutic purposes.
Other: Platform sham
Whole body vibration training will consist of 12 consecutive weeks with two sessions per week on alternate days. Initially, before training with the vibratory platform, stretches lasting 5 to 10 minutes will be performed, with a series of 60 seconds for each of the following muscle groups: pectorals, sternocleidomastoids, scalenes, quadriceps and ischiatibial muscles. Patients will be monitored through vital signs for follow-up.
will receive the treatment without the therapeutic effect of the platform, but with vibrating platform connected with the display lit and a sound device coupled with a noise recording generated by the vibration, but without therapeutic purposes.
Quadriceps muscle strength
Will be performed the examination of the Maximum Voluntary Isometric Contraction
Time frame: 20 minutes
Functional capacity
The 6-minute walk test will be used
Time frame: 10 minutes
Respiratory muscle strength
Will be performed through the manocacuometry with the evaluation of the maximum respiratory pressures
Time frame: 20 minutes
Thickness of the quadriceps
This measure will be obtained through the portable Ultrasound
Time frame: 10 minutes
Postural balance
The static and dynamic postural balance will be evaluated through the Biodex Balance System
Time frame: 20 minutes
Pulmonary function
Slow and forced spirometry will be used
Time frame: 15 minutes
Risk of fall
The International Fall Efficiency Scale (FES-I) will be used
Time frame: 5 minutes
Level of physical activity
It will be evaluated by the International Physical Activity Questionnaire
Time frame: 5 minutes
Quality of life
Will be applied the Medical Outcomes Study Quality of Life Questionnaire - Short-Form Health Survey
Time frame: 10 minutes
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidade Federal de Pernambuco